Summary
For Year 2026-27, Valiant Laboratories reports the following shareholding: Total Promoters at 74.94%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.01%, Domestic Institutional Investors at 0%, and Retail at 25.05%. This breakdown provides a quick snapshot of ownership distribution for Valiant Laboratories in 2026-27.
Valiant Laboratories FAQs
As of 04-2026, the promoter shareholding in Valiant Laboratories stands at 74.94% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Valiant Laboratories is 0.01% and 0% respectively.
The retail shareholding of the Valiant Laboratories is 25.05%.
Changes in shareholding patterns of Valiant Laboratories can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Valiant Laboratories are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Valiant Laboratories Associated Pages
